Nonketotic hyperglycemia-related epileptic seizures by unknown





Objective: To investigate nonketotic hyperglycemia (NKH)-related epileptic clinical features and pathogenesis, and
improve the diagnosis and treatment.
Methods: Clinical data, including the clinical manifestations, laboratory tests, imaging studies and other
information, of 13 patients with hyperglycemia-related epilepsy in our department were retrospectively analyzed.
Results: Blood glucose levels of the 13 patients when admitted to the hospital ranged between 24.7-34.6 mmol/L
(average 28.3 mmol/L), their plasma osmolality ranged between 290–332 mOsm/L (average 308 mOsm/L), and their
ketone results were negative. Among them, seven had convulsions, 4 had upper limbs and facial twitching, and 2
had bust twitch. Imaging findings could not detect accountable lesions related to seizures. EEG mainly showed
spikes, slow waves, and scattered sharp slow waves. Insulin combined short-term antiepileptic drugs, allowed the
epilepsy to be effectively controlled without recurrence.
Interpretation: Patients with episodes of NKH epilepsy increased significantly with hyperglycemia. Raising
awareness of the disease, early diagnosis, and very early lowering the hyperglycemia levels, can effectively control
the seizures. Lowering blood glucose is an effective way to control blood glucose levels.
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Nonketotic hyperglycemia (NKH)-related epileptic
seizures can be diagnosed when high blood glucose ac-
companied with normal plasma osmolality and negative
urine ketone occurs. Its initial symptoms are seizures.
They are clinically rare, and patients might not have
prior history of diabetes or onset of diabetic symptoms.
Because epileptic seizures related to NKH significantly
affect neurological outcomes and may cause misdiag-
nosis or missed diagnosis, more attention should be paid
to them. In this article, NKH epilepsy patients, who were
treated in our department from December 2009 to
October 2014, were clinical analyzed, in order to
facilitate the future treatment.
Material and methods
Ethics statement
This research has been approved by the ethics committee
of the Second Hospital affiliated to Nantong University.
Informed consent has been obtained and this investigation
has been conducted according to the principles expressed
in the Declaration of Helsinki.
General information
Thirteen cases of NKH-related epileptic seizures were
treated from December 2009 to October 2014 in our
neurosurgery department. Among them, 8 were males,
and 5 females, aged 45–80 years old (mean age: 54 ±
2 years old). Their diabetes duration was between 0 and
10 years (mean 4.7 years). Diagnosis of diabetes was
performed according to the WHO diagnostic criteria.
The results showed that 9 patients had type 2 diabetes,
and 5 had a history of type 2 diabetes. None of them
had history of contacting the toxic substances, epilepsy,
or family history of epilepsy.
Signs and symptoms
Convulsive site during epilepticus insultus: convulsions
occurred in seven cases, with 4 of them having upper
limb and facial twitching, and 2 with bust twitch.
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Unconsciousness seizures occurred in eight cases, with
the onset of the interval from 10 min ~ 2 h, lasting for
4–20 min. Among those 8 cases, five were in persistent
state.
Supplementary examination
Head imaging test did not find lesions that accounted
for seizures. Laboratory tests at the admission: several
cases with levels of venous blood glucose and peripheral
blood glucose considerablely higher than the critical
value of the for diabetes diagnosis, blood glucose 24.7–
34.6 (average 28.3) mmol/L; plasma osmolality 296–322
(average 308) mOsm/L, did not reach the diabetic hyper-
osmolar (>350 mOsm/L) of the diagnostic criteria.
When seizures were under control, average blood glu-
cose was 13.6 mmol/L. Potassium, calcium and phos-
phorus were generally within the normal ranges, and
blood urea nitrogen and serum creatinine also in the
normal range. EEG showed spike, slow waves, scattered
sharp slow wave in 8 cases.
Treatment
Once newly epileptic seizure was diagnosed, antiepileptic
treatment was immediately conducted. Intramuscular ad-
ministration of phenobarbital, diazepam and valproate, or
valproate combined with carbamazepine was applied in
defined cases, but with suboptimal results. After blood
glucose levels increased, insulin infusion or subcutaneous
injection were immediate applied. Close monitoring of
blood glucose, saline rehydration and aggressiveness
simultaneously corrected acid-base unbalance and water
and electrolyte disorders. If blood glucose levels dropped
to 8-15 mmol/L and epileptic episodes stopped, the anti-
epileptic drugs would be discontinued.
Results
The selected 13 patients were cured, as their seizures
disappeared. The treatment procedures lasted 11–76 h
(average 23 h). After reduction of the blood glucose level
by insulin, rehydration, and control of epilepsy, the
number of seizures gradually reduced. The patients’ con-
dition gradually improved and eventually regained the
consciousness without nervous system dysfunction left.
The average blood glucose when epileptic seizures ended
was 10 mmol/L. Anti-epileptic drugs were not pre-
scribed after discharge. During the two-month to one-
year follow-up, no recurrent seizure appeared.
Discussions
Focal seizures (also known as partial seizure) induced by
hyperglycemia were first reported by Maccario et al in
1965 [1–3]. They were often encountered in clinical
practice and characterized by hyperglycemia without
keto-acidosis. Seizure control associated with resolution
of the hyperglycemia was usually used to manage the
partial seizures [2, 4]. Many studies have described this
clinical syndrome [5–7]. In recent years, clinical reports
gradually increased about NKH-related epileptic
seizures, which are considered one of the major neuro-
logical complications of diabetes [3, 8]. It indicates an
unsatisfactory blood glucose control if NKH-related
epileptic seizures occur [6].
For patients with seizures as main manifestations, es-
pecially those without a history of diabetes, the initial
diagnosis would often be neurology-related. If conven-
tional antiepileptic treatment is applied, the results
would be more harmful than beneficial, and in few ill
cases, increased mortality might be observed. The pos-
sible explanations include: (1) these patients are more
frequently accompanied with unconsciousness and sei-
zures. The preferred drugs, such as diazepam and
phenobarbital that ends epileptic episode, often aggra-
vated the unconscious patients by causing respiration in-
hibition, making the disease more complicated and
affecting the subsequent diagnosis and treatment; (2)
treatment of intractable seizures uses anti-epilepsy medi-
cine that involves multi-combination of mannitol, corti-
costeroids and other drugs to reduce brain edema;
however, the risk factors of the focal seizure disease are
high-blood glucose, high permeability and intracellular
dehydration. These drugs will inevitably aggravate the
patient's condition; (3) NKH: featured with reduction of
brain γ-aminobutyric acid content, and therefore diaze-
pam and phenobarbital actually decreased the antiepi-
leptic effect; (4) Since glucose saline injection is
commonly used as intravenous drugs in the absence of
insulin, it might worsen the condition. The disease tend
to cause seizures in some patients without diabetes his-
tory, and therefore it is more difficult to catch the atten-
tion, and more likely to be misdiagnosed.
Diabetes is the most common cause of the seizures in
patients with low blood glucose. The subsequent uncon-
sciousness with ketosis acidosis and NKH coma are
more common in clinical practice; however, high blood
glucose can also lead to seizures, even status epilepticus
without awareness. Careful analysis the patients who had
epilepsy, accompanied with occasional onset of uncon-
sciousness in this group, first found significantly in-
creased biochemical blood glucose levels, leading to the
exclusion of the possibility of hypoglycemia. Diabetes
can be complicated by acidosis or ketosis ketotic hyper-
osmolar coma. As their urine ketone was negative, the
possibility of ketosis acidosis could next be ruled out.
Blood biochemistry showed that their glucose, sodium,
and potassium, were only slightly elevated, and so was
the blood urea nitrogen content in plasma osmolality
values inferred, which was less than 350 mOsm/L, non-
ketotic diabetic hyperosmolar coma was also excluded.
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Therefore, NKH-related epileptic seizures should be next
considered. The seizures pathogenesis caused by this
disease is still controversial, as some people think that
the main pathogenesis is the lack of insulin. Among the
patients, insulin levels are sufficient to inhibit the free
fatty acid metabolism and the subsequent ketoacidosis,
but not enough to transport glucose into the cells [9].
High blood glucose levels increase the levels of urine
glucose, causing osmotic diuresis effect and progressive
dehydration, which would in turn increase the incidence
of this disease. Some people believe that the possible
mechanisms include high blood glucose, high plasma
osmolality and γ- aminobutyric acid (GABA) levels, and
low focal cerebral ischemia [8]. Specific mechanisms also
include: (1) osmotic changes. Hyperglycemia causes
significant and rapid increase of intracellular osmotic
pressure, leading to nerve cell dehydration, and changes
in enzyme activity and brain cell energy metabolism.
Membrane ion pump function is impaired, causing the
loss of intracellular potassium and the subsequent so-
dium accumulation, which destroys the membrane po-
tential and the stability of cell depolarization, ultimately
resulting in seizures [4]. (2) in vivo biochemical changes
in metabolism. Citric acid cycle is inhibited in vivo in
the patients with this disease, whereas GABA metabol-
ism is increased, causing the increased brain energy con-
sumption, and the reduced seizure threshold [10]. In
contrast, seizures are less frequent in ketoacidosis pa-
tients, as ketosis acidosis increases intracellular activities
of glutamate and tryptophan decarboxylase, leading to
the increased content of brain inhibitory neurotransmit-
ter GABA. GABA is related to the rapid changes of syn-
aptic sensitivities by binding to the neurons, which then
increases the permeability of chloride ions. Under such
conditions, the membrane potential is maintained at a
stable resting potential level and the excitatory synaptic
reactivities are weakened so that the epilepsy is pre-
vented. This is also an alternative way to prove that the
GABA contents decrease in NKH-related epileptic
seizures patients. (3) brain cell energy deficiency. Be-
cause of the diabetic hyperglycemia, plasma fibrinogen
significantly increases, red blood cell and platelet aggre-
gate, and blood is in a hypercoagulable state. In addition,
the aggravation of existing diabetes microcirculation and
small artery hyalinization, the dysfunction of endothelial
cells, and damages of cerebral blood flow autoregulation,
decrease regional cerebral blood flow, causing hypoxic-
ischemic damages and functional changes in cortical
cells, which are “epilepsy cells”. Such cells are sensitive
to the metabolic disorders, high blood glucose condition
especially is likely to cause seizures (4) immune abnor-
malities: the presence of glutamic acid decarboxylase
autoantibodies in both type 1 diabetes and epilepsy.
Peltola, et al studied 51 cases of refractory epilepsy and
found that these patients were autoantibody positive,
with antibody titers similar to that in patients with type
1 diabetes, suggesting that intrinsic link might exist
between them Their results supported the idea that im-
mune dysfunction was involved in the hyperglycemia-
related epilepsy [11] (5) studies suggest that NKH-
related seizures might be linked to the brain barrier
damage caused by long-term high blood glucose [12].
However, most of patients do not have seizures even if
their blood glucose levels are high as the high levels of
blood glucose are not the only factor for epilepsy. Other
factors include individual health status and genetic fac-
tors [7]. In 1968, Maccario et al. [2, 3] first reported that
NKH and partial seizures co-existed, which were
featured with high blood glucose, absence of ketosis,
consciousness, and partial seizures. Tiamkao et al. [8],
based on a retrospective analysis of 2 l partial NKH-
related seizures patients, found that the average blood
glucose level was 32.6 l mmol/L(16.11 ~ 61.33 mmol/L),
and mean plasma osmolality was 302 mOsm/L (288-
323 mOsm/L). When the seizure was under control, the
average of blood sugar level was 11.3 mmol/L (4.11-
21.67 mmol/L).
This paper reported eight cases with EEG showing
spikes, slow waves, and scattered sharp slow waves. In
previously published reports, EEG results of patients
with NKH-related epileptic seizures have shown normal
waves or spikes, sharp slow or high amplitude slow
waves [13]. Therefore, EEG is not very valuable in diag-
nosis of the disease. Imaging is not specific, either. This
group mostly showed the normal imaging results, or
age-related abnormalities such as old lacunar infarction,
brain atrophy, and white matter demyelination, similar
to most of the previous studies [5, 6]. However, some
studies [14–16] described a transient change in head
MRI in a patient with NKH-induced seizures, that is, the
reversible and Flair weighted hyperintense cortex, and
low signal of white matter. He also displayed cytotoxic
edema. Its mechanism was unclear. Possibly, the cortical
ischemia seizures and angioedema, caused aggregation
and deposition of iron radicals [14–16]. Some scholars
believe that these changes result from the damages in
blood-brain barrier caused by long-term high levels of
blood sugar [12].
This article summarized the following clinical features
of NKH-related epileptic seizures: (1) common in the eld-
erly (2) with or without a previous history of diabetes and
epilepsy (3). Seizures were always accompanied with a
rapid rise in blood glucose. Plasma osmolality may be nor-
mal or slightly elevated, but not to the diagnostic criteria
for diabetes hypertonic (4) urine ketone negative (5).
Seizures could not be effectively alleviated by antiepileptic
drugs alone. Application of insulin to correct hypergly-
cemia and metabolic disorders ended the seizures (6)
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seizure-related lesions were not detected in the head im-
aging tests (7). If blood glucose was under control, epi-
lepsy did not occur any more. Analysis from the clinical
effectiveness showed that the primary treatment for the
NKH-related epileptic seizures included early, active, and
rational rehydration and insulin hypoglycemic therapy,
while closely monitoring blood glucose. Such treatments
are key to the success of salvage therapy among these pa-
tients. Phenytoin-induced insulin resistance can inhibit
the release of insulin, and therefore increase the possibility
of NKH-related seizures. Diazepam increase the opening
frequency of GABA-mediated chloride ion channel.
Phenobarbital extended the start time of GABA-mediated
chloride channel, by reducing the brain GABA levels
among the patients with NKH-related seizures, Therefore,
the stability and antiepileptic effects of phenobarbital and
Diazepam decline [2, 5–7] which explained why conven-
tional antiepileptic drugs in those patients with epilepsy
were not marketly effective. Antiepileptic drugs preferred
include carbamazepine, clonazepam diazepam and other
anti-epileptic drugs as they do not affect the levels of
blood glucose. Long-term use of anti-epileptic drugs is not
necessary. If blood glucose and the seizures are well con-
trolled, anti-epileptic drugs can be discontinued gradually.
Smooth phasing out the anti-epileptic drugs among the
patients in the present study did not cause the recurrence.
In short, NKH-related epileptic seizures has low oc-
currence rate in clinical practice. Epilepsy is often the
first symptom. Compared with other diseases presenting
clinical manifestations of epilepsy, they are not specific,
and tend to be misdiagnosed. Therefore, early recogni-
tion of this clinical syndrome and other seizure causes
as well as early phase identification is critical, because
the condition can be corrected by adjusting blood glu-
cose level plus rapid rehydration. The disease pathogen-
esis is not entirely clear. In order to clarify the clinical
features and pathogenesis of this disease, further re-
search should be carried out in the imaging and electro-
physiological aspects.
Acknowledgements
We didn’t receive any financial support to analyze this data and we didn’t
have any financial interest in any materials or devices described.
Funding
This research supported by: (1) Young Medical Project of Nantong City
Health Bureau(WQ2014016); (2) Traditional Chinese medicine science and
technology project in Jiangsu province(No. YB2015113); (3) the science and
technology program of Nantong city (no. : MS12015016).
Availability of data and materials
Please contact author for data requests.
Author’s contributions
All by Xuejian Wang.
Competing interests
The author declares that he has no competing interests.
Consent for publication
All authors have approved the manuscript and agree with submission to
Journal of Chinese Neurosurgical Journal.
Ethics approval and consent to participate
This research has been approved by the ethics committee of the Second
Hospital affiliated to Nantong University. Informed consent has been
obtained and this investigation has been conducted according to the
principles expressed in the Declaration of Helsinki.
Received: 8 September 2016 Accepted: 10 January 2017
References
1. Wang X, Yu H, Cai Z, et al. Nonketotic hyperglycemia-related epileptic
seizures. Epilepsy Behav Case Rep. 2013;1:77–8.
2. Maccario M, Messis CP, Vastola EF. Focal seizures as a manifestation of
hyperglycemia without ketoacidosis. A report of seven cases with review of
thw literature. Neurology. 1965;15:195–206.
3. Maccario M. Neurological dysfunction associated with nonketotic
hyperglycemia. Arch Neurol. 1968;19(5):525–34.
4. Singh BM, Gupta DR, Strobos RJ. Nonketotic hyperglycemia and epilepsia
partialis continua. Arch Neurol. 1973;29(3):187–90.
5. Lammouchi T, Zoghlami F, Ben Slamia L, et al. Epileptic seizures in non-
ketotic hyperglycemia. Neurophysiol Clin. 2004;34(3-4):183–7.
6. Scherer C. Seizures and non-ketotic hyperglycemia. Presse Med. 2005;34(15):
1084–6.
7. Huang CW, Tsai JJ, Ou HY, et al. Diabetic hyperglycemia is associated with
the severity of epileptic seizures in adults. Epilepsy Res. 2008;79(1):71–7.
8. Tiamkao S, Pratipanawatr T, Tiamkao S, Nitinavakarn B, et al. Seizures in
nonketotic hyperglycaemia. Seizure. 2003;12(6):409–10.
9. Lavin PJ. Hyperglycemic hemianopia: a reversible complication of non-
ketotic hyperglycemia. Neurology. 2005;65(4):616–9.
10. Brick JF, Gutrecht JA, Ringel RA. Reflex epilepsy and nonketotic
hyperglycemia in the elderly: a specific neuroendocrine syndrome.
Neurology. 1989;39(3):394–9.
11. Peltola J, Kulmala P, Isojärvi J, et al. Autoantibodies to glutamic acid
decarboxylase in patients with therapy-resistant epilepsy. Neurology. 2000;
55(1):46–50.
12. Kim DW, Moon Y, Gee Noh H, et al. Blood-brain barrier disruption is
involved in seizure and hemianopsia in nonketotic hyperglycemia.
Neurologist. 2011;17(3):164–6.
13. Taieb-Dogui T, Harzallah MS, et al. Acute repetitive giratory seizures as a
manifestation of nonketotic hyperglycemia. Neurophysiol Clin. 2002;32(4):254–7.
14. Seo DW, Na DG, Na DL, et al. Subcortical hypointensity in partial status
epilepticus associated with nonketotic hyperglycemia. J Neuroimaging.
2003;13(3):259–63.
15. Raghavendra S, Ashalatha R, Thomas SV, Kesavadas C. Focal neuronal loss,
reversible subcortical focal T2 hypointensity in seizures with a nonketotic
hyperglycemic hyperosmolar state. Neuroradiology. 2007;49(4):299–305.
16. Goto H, Kumagai T, Momozaki N. MRI findings of occipital seizures in non-
ketotic hyperglycemia. Intern Med. 2011;50(4):367–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Wang Chinese Neurosurgical Journal  (2017) 3:16 Page 4 of 4
